Optical coherence tomography in Alzheimer's disease
Alzheimer’s disease (AD) is a neurodegenerative disorder, which starts as mild cognitive impairment (MCI) several years before its full-blown clinical manifestation. In the last two decades, optical coherence tomography (OCT) has been used to measure a significant loss in peripapillary retinal nerve fiber layer (RNFL) and in macular thickness and volume in patients affected by a form of mild to severe dementia. These morphological abnormalities correlate to some extent with the severity of the disease as evaluated with neuropsychological tests.